The decision was approved by all members of the regulator’s board at a meeting on Monday broadcast on the YouTube portal.
"I want to stress that this decision reflects the current situation and was made on the basis of what we have managed to analyze today," the head of the agency, Antonio Barra Torres, said.
The meeting took more than four hours and considered conclusions of the agency’s experts and their views on the Russian drug’s safety and efficacy.
No comments:
Post a Comment
Only News